EAP Webinar – Every Childhood Matters

15 May 2025

Children are among the most vulnerable to the often-overlooked harms of alcohol exposure — yet policies and public discourse rarely centre their needs. This timely webinar places children and adolescents at the core of Europe’s alcohol harm reduction efforts.

Building on the themes of the European Alcohol Health Alliance Symposium, the session will explore how children are affected at every stage — from prenatal exposure to the impacts of parental misuse, societal consumption, and pervasive alcohol marketing.

Our expert line-up includes Catherine Paradis (WHO Regional Office for Europe), Frank Murray (Alcohol Action Ireland, EASL), and Ann De Guchtenaere (European Academy of Paediatrics), with opening remarks and welcome by the moderator. Together, they will share key evidence, advocacy strategies, and policy actions aimed at reducing alcohol harm across Europe.

Join us for an urgent conversation calling for stronger protections, stricter regulations, and a cultural shift that truly prioritises children’s wellbeing in alcohol policy and prevention.

What You Will Walk Away With

  • A deeper understanding of how alcohol exposure impacts children at all stages of development.
  • Key evidence and data to support advocacy efforts.
  • Insights on the role of paediatricians in promoting alcohol harm reduction through awareness, education, and public health advocacy.
  • Insights into the latest European initiatives aimed at reducing alcohol-related harm among young populations.
  • Tools to help shift the narrative toward prioritising child health in alcohol policy discussions.

Enjoy the Recording Below

About the Presenters

Catherine Paradis

Technical Officer for Alcohol, Special Initiative on NCDs and Innovation, WHO Regional Office for Europe

Frank Murray

EASL Policy, Public Health & Advocacy Committee Member & Chair of Alcohol Action Ireland

Ann de Guchtenaere

Representative of the EAP at the European Alcohol Health Alliance Symposium

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

""
 

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more